Explore more publications!

Press Releases

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
ESO Launches Logis Dispatch PrepIQ, Enabling Risk-Free Training for Emergency Communications Centers and Health Systems to Improve Performance and Outcomes
AISLE Discovers 38 Critical Security Vulnerabilities in Healthcare Software Used by 100,000 Providers
New Comprehensive Report Analyzes Risks of Nanoplastics to Human Health, Ecosystems, and the Environment
New Cochrane Review Questions Alzheimer’s Drugs; Czech Company Unveils Alternative
SUSE Honors Global Innovators with 2026 Customer Awards at SUSECON Prague
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
HIPTHER Prague Summit 2026 Becomes History: 400 Industry Leaders Celebrate 10 Years of Impact in a Landmark Edition
ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems
Pharmaceutical Glass Packaging Market Forecast 2026-2036: Global Market To Reach USD 14.2 Billion by 2036 at a 5.1% CAGR
ORYZON to Participate in Upcoming Events in May and June
Elevara Medicines Doses First Patient in Phase 2b START-SYNERGY Trial of ELV001 in Rheumatoid Arthritis Patients with Incomplete Response to TNFi
Tech Startups Pitch Investors at Czech Night at SXSW
Primary Ovarian Insufficiency Market 2026: Explore Emerging Treatments Addressing Unmet Women’s Health Needs
ESO Wave Convenes Emergency Services and Healthcare Leaders To Advance Data-Driven Outcomes
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Medical Courier Market Competition Analysis 2025: How Players Are Shaping Growth
Multibillion-Dollar Edibles Market Gains Rising Momentum as Legalization Expands
Asian Egg Bank Announces Renewed Partnership With CAN-AM Cryoservices for Canadian Patients and Clinics
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions